PharmacoEconomics - open
Incremental Disease Burden (Healthcare Costs and Resources) of Duchenne Muscular Dystrophy in the US: A Matched Cohort Analysis.
Mena Scavina, Nate Posner, Patricia Dorling, Anna Talaga, Anna Stachel, Jose Alvir
Published: 202610.1007/s41669-025-00612-z
Abstract
BACKGROUND: Duchenne muscular dystrophy (DMD) is a rare genetic condition that causes progressive muscle weakness and reduced life expectancy. Detailed economic studies on the impact of DMD disease burden, costs, and healthcare resource utilization (…
Preview only. Read the full abstract at the source